Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Multiple FDA approvals and strong launch momentum for new therapies highlight a year of strategic success. Key programs in sHTG, HAE, and HBV are advancing, while competitive positioning and pipeline innovation remain priorities.Based on Ionis Pharmaceuticals, Inc. [IONS] Wells Fargo 21st Annual He…
Multiple FDA approvals and strong product launches mark a year of strategic success, with TRYNGALZA and DAWNZERA gaining rapid traction and robust sales outlooks. Pipeline advances include siRNA programs and anticipated regulatory milestones for HBV and IgA nephropathy.Based on Ionis Pharmaceutical…